AG˹ٷ

STOCK TITAN

[8-K] Nektar Therapeutics Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

BlackRock MuniVest Fund, Inc. (NYSE: MVF) has triggered its discount-management program and will launch an issuer tender offer for 2.5% of its outstanding common shares. The trigger was activated because the Fund’s shares traded at an average daily discount of -7.60% to net asset value (NAV) during the 1 April � 30 June 2025 measurement period, exceeding the 7.50% threshold. The tender offer will commence 15 July 2025 and expire 15 August 2025 at 5:00 p.m. ET, unless extended. Shareholders who tender will receive 98% of NAV calculated on the first business day following the expiration (or any extension) of the offer. If tenders exceed 2.5% of shares outstanding, purchases will be prorated. Payment is expected within five business days after expiration.

The initiative is intended to narrow MVF’s market discount, enhance long-term shareholder value and provide near-term liquidity, although the Fund explicitly notes that no assurance can be given regarding any discount reduction. Full terms will be detailed in the Offer to Purchase and related Schedule TO filings that will become available on the SEC’s website once the offer begins.

BlackRock MuniVest Fund, Inc. (NYSE: MVF) ha attivato il suo programma di gestione dello sconto e lancerà un'offerta di acquisto da parte dell'emittente per il 2,5% delle azioni ordinarie in circolazione. L'attivazione è avvenuta perché le azioni del Fondo hanno registrato uno sconto medio giornaliero del -7,60% rispetto al valore patrimoniale netto (NAV) nel periodo di rilevazione dal 1° aprile al 30 giugno 2025, superando la soglia del 7,50%. L'offerta di acquisto avrà inizio il 15 luglio 2025 e scadrà il 15 agosto 2025 alle ore 17:00 ET, salvo proroghe. Gli azionisti che aderiranno riceveranno il 98% del NAV calcolato nel primo giorno lavorativo successivo alla scadenza (o a qualsiasi proroga) dell'offerta. Se le adesioni supereranno il 2,5% delle azioni in circolazione, gli acquisti saranno proporzionati. Il pagamento è previsto entro cinque giorni lavorativi dalla scadenza.

L'iniziativa mira a ridurre lo sconto di mercato di MVF, aumentare il valore a lungo termine per gli azionisti e fornire liquidità a breve termine, anche se il Fondo specifica che non è garantita alcuna riduzione dello sconto. I termini completi saranno dettagliati nell'Offerta di Acquisto e nei relativi documenti Schedule TO, disponibili sul sito della SEC una volta avviata l'offerta.

BlackRock MuniVest Fund, Inc. (NYSE: MVF) ha activado su programa de gestión de descuentos y lanzará una oferta pública de adquisición por parte del emisor para el 2.5% de sus acciones comunes en circulación. El activador se disparó porque las acciones del Fondo se negociaron con un descuento diario promedio de -7.60% respecto al valor neto de los activos (NAV) durante el período de medición del 1 de abril al 30 de junio de 2025, superando el umbral del 7.50%. La oferta comenzará el 15 de julio de 2025 y finalizará el 15 de agosto de 2025 a las 5:00 p.m. ET, salvo prórroga. Los accionistas que presenten sus acciones recibirán el 98% del NAV calculado el primer día hábil después de la expiración (o cualquier extensión) de la oferta. Si las presentaciones superan el 2.5% de las acciones en circulación, las compras se prorratearán. El pago se espera dentro de los cinco días hábiles posteriores a la expiración.

La iniciativa tiene como objetivo reducir el descuento de mercado de MVF, aumentar el valor a largo plazo para los accionistas y proporcionar liquidez a corto plazo, aunque el Fondo señala explícitamente que no se garantiza ninguna reducción del descuento. Los términos completos se detallarán en la Oferta de Compra y los documentos Schedule TO relacionados, que estarán disponibles en el sitio web de la SEC una vez que comience la oferta.

BlackRock MuniVest Fund, Inc. (NYSE: MVF)� 할인 관� 프로그램� 발동여 발행� 공개 매수 제안� 통해 발행 주식� 2.5%� 대� 매수� 시작합니�. � 프로그램은 2025� 4� 1일부� 6� 30일까지 측정 기간 동안 펀� 주식� 순자산가�(NAV) 대� 평균 일일 할인� -7.60%� 거래되어 7.50% 임계값을 초과했기 때문� 발동되었습니�. 공개 매수� 2025� 7� 15일에 시작2025� 8� 15� 오후 5�(동부 시간)까지 만료되며, 연장� � 있습니다. 제안� 응한 주주들은 공개 매수 만료(또는 연장) 다음 � 번째 영업일에 계산� NAV� 98%� 받게 됩니�. 만약 응찰 주식� 발행 주식� 2.5%� 초과하면 매수� 비례 배분됩니�. 대� 지급은 만료 � 5영업� 이내� 이루어질 예정입니�.

� 조치� MVF� 시장 할인율을 줄이� 장기 주주 가치를 높이� 단기 유동성을 제공하는 것을 목표� 하지�, 펀드는 할인� 감소� 대� 보장� 명시적으� 하지 않습니다. 전체 조건은 공개 매수 시작 � SEC 웹사이트에서 확인� � 있는 매수 제안� � 관� Schedule TO 문서� 자세� 나와 있습니다.

BlackRock MuniVest Fund, Inc. (NYSE : MVF) a déclenché son programme de gestion des décotes et lancera une offre publique de rachat par l’émetteur portant sur 2,5 % de ses actions ordinaires en circulation. Le déclencheur a été activé car les actions du Fonds se sont négociées avec une décote moyenne quotidienne de -7,60 % par rapport à la valeur nette d’inventaire (VNI) durant la période de mesure du 1er avril au 30 juin 2025, dépassant le seuil de 7,50 %. L’offre débutera le 15 juillet 2025 et prendra fin le 15 août 2025 à 17h00 (heure de l’Est), sauf prolongation. Les actionnaires qui présenteront leurs titres recevront 98 % de la VNI calculée le premier jour ouvrable suivant l’expiration (ou toute prolongation) de l’offre. Si les offres excèdent 2,5 % des actions en circulation, les achats seront proratisés. Le paiement est prévu dans les cinq jours ouvrables suivant l’expiration.

Cette initiative vise à réduire la décote de marché de MVF, à accroître la valeur à long terme pour les actionnaires et à fournir une liquidité à court terme, bien que le Fonds précise explicitement qu’aucune garantie ne peut être donnée quant à une réduction de la décote. Les conditions complètes seront détaillées dans l’Offre d’Achat et les documents Schedule TO associés, qui seront disponibles sur le site de la SEC dès le début de l’offre.

BlackRock MuniVest Fund, Inc. (NYSE: MVF) hat sein Discount-Management-Programm ausgelöst und wird ein Emittenten-Rückkaufangebot für 2,5 % seiner ausstehenden Stammaktien starten. Der Auslöser wurde aktiviert, weil die Aktien des Fonds im Zeitraum 1. April bis 30. Juni 2025 mit einem durchschnittlichen Tagesabschlag von -7,60% gegenüber dem Nettoinventarwert (NAV) gehandelt wurden und damit die Schwelle von 7,50 % überschritten haben. Das Rückkaufangebot beginnt am 15. Juli 2025 und endet am 15. August 2025 um 17:00 Uhr ET, sofern keine Verlängerung erfolgt. Aktionäre, die Aktien anbieten, erhalten 98 % des NAV, berechnet am ersten Geschäftstag nach Ablauf (oder Verlängerung) des Angebots. Wenn die Angebote 2,5 % der ausstehenden Aktien übersteigen, erfolgt eine Quotierung der Käufe. Die Zahlung erfolgt voraussichtlich innerhalb von fünf Geschäftstagen nach Ablauf.

Die Maßnahme soll den Marktabschlag von MVF verringern, den langfristigen Aktionärswert steigern und kurzfristige Liquidität bereitstellen, wobei der Fonds ausdrücklich darauf hinweist, dass keine Garantie für eine Reduzierung des Abschlags gegeben werden kann. Die vollständigen Bedingungen werden im Kaufangebot und den zugehörigen Schedule-TO-Unterlagen detailliert beschrieben, die auf der Website der SEC verfügbar sein werden, sobald das Angebot beginnt.

Positive
  • Tender offer provides liquidity at 98% of NAV, enabling investors to exit near intrinsic value.
  • Accretive buyback: repurchasing below NAV slightly boosts NAV per share for remaining holders.
  • Demonstrates management’s commitment to its discount-management policy, supporting investor confidence.
Negative
  • Limited scale: only 2.5% of shares are eligible, so many tendering investors may be prorated.
  • Repurchase price below NAV means shareholders still sell at a 2% haircut to intrinsic value.
  • No guarantee of sustained discount narrowing; historical discount could persist after tender.

Insights

TL;DR � Small but shareholder-friendly tender may modestly tighten MVF’s discount.

MVF is activating its self-imposed discipline by buying back 2.5% of shares at 98% of NAV after a >7.5% discount persisted. While the size is limited, the tender (�$28�30 million assuming a $12 NAV and 115 million shares) removes stock below intrinsic value, immediately accreting NAV per share by roughly 2% on the repurchased slice and signaling management’s commitment to discount control. Because purchases are prorated, the near-term price impact should be mild; however, historical evidence suggests that recurring tenders improve trading ranges over time. Liquidity for retail holders is also enhanced. The tender is incrementally positive but not transformational.

TL;DR � Event is neutral-to-positive; impact depends on follow-through and market sentiment.

At 2.5% of float, the buyback will have limited effect on leverage or earnings. Paying 98% of NAV allows the Fund to retire shares at a discount, delivering a slight accretion to remaining holders. Yet, because the offer follows a rule-based trigger, investors may have already priced in the possibility, muting upside. The discount could narrow temporarily but may widen again absent further actions or improved muni-market fundamentals. I view the move as a modest positive—supportive of shareholder alignment, but not enough to shift the core valuation thesis on MVF.

BlackRock MuniVest Fund, Inc. (NYSE: MVF) ha attivato il suo programma di gestione dello sconto e lancerà un'offerta di acquisto da parte dell'emittente per il 2,5% delle azioni ordinarie in circolazione. L'attivazione è avvenuta perché le azioni del Fondo hanno registrato uno sconto medio giornaliero del -7,60% rispetto al valore patrimoniale netto (NAV) nel periodo di rilevazione dal 1° aprile al 30 giugno 2025, superando la soglia del 7,50%. L'offerta di acquisto avrà inizio il 15 luglio 2025 e scadrà il 15 agosto 2025 alle ore 17:00 ET, salvo proroghe. Gli azionisti che aderiranno riceveranno il 98% del NAV calcolato nel primo giorno lavorativo successivo alla scadenza (o a qualsiasi proroga) dell'offerta. Se le adesioni supereranno il 2,5% delle azioni in circolazione, gli acquisti saranno proporzionati. Il pagamento è previsto entro cinque giorni lavorativi dalla scadenza.

L'iniziativa mira a ridurre lo sconto di mercato di MVF, aumentare il valore a lungo termine per gli azionisti e fornire liquidità a breve termine, anche se il Fondo specifica che non è garantita alcuna riduzione dello sconto. I termini completi saranno dettagliati nell'Offerta di Acquisto e nei relativi documenti Schedule TO, disponibili sul sito della SEC una volta avviata l'offerta.

BlackRock MuniVest Fund, Inc. (NYSE: MVF) ha activado su programa de gestión de descuentos y lanzará una oferta pública de adquisición por parte del emisor para el 2.5% de sus acciones comunes en circulación. El activador se disparó porque las acciones del Fondo se negociaron con un descuento diario promedio de -7.60% respecto al valor neto de los activos (NAV) durante el período de medición del 1 de abril al 30 de junio de 2025, superando el umbral del 7.50%. La oferta comenzará el 15 de julio de 2025 y finalizará el 15 de agosto de 2025 a las 5:00 p.m. ET, salvo prórroga. Los accionistas que presenten sus acciones recibirán el 98% del NAV calculado el primer día hábil después de la expiración (o cualquier extensión) de la oferta. Si las presentaciones superan el 2.5% de las acciones en circulación, las compras se prorratearán. El pago se espera dentro de los cinco días hábiles posteriores a la expiración.

La iniciativa tiene como objetivo reducir el descuento de mercado de MVF, aumentar el valor a largo plazo para los accionistas y proporcionar liquidez a corto plazo, aunque el Fondo señala explícitamente que no se garantiza ninguna reducción del descuento. Los términos completos se detallarán en la Oferta de Compra y los documentos Schedule TO relacionados, que estarán disponibles en el sitio web de la SEC una vez que comience la oferta.

BlackRock MuniVest Fund, Inc. (NYSE: MVF)� 할인 관� 프로그램� 발동여 발행� 공개 매수 제안� 통해 발행 주식� 2.5%� 대� 매수� 시작합니�. � 프로그램은 2025� 4� 1일부� 6� 30일까지 측정 기간 동안 펀� 주식� 순자산가�(NAV) 대� 평균 일일 할인� -7.60%� 거래되어 7.50% 임계값을 초과했기 때문� 발동되었습니�. 공개 매수� 2025� 7� 15일에 시작2025� 8� 15� 오후 5�(동부 시간)까지 만료되며, 연장� � 있습니다. 제안� 응한 주주들은 공개 매수 만료(또는 연장) 다음 � 번째 영업일에 계산� NAV� 98%� 받게 됩니�. 만약 응찰 주식� 발행 주식� 2.5%� 초과하면 매수� 비례 배분됩니�. 대� 지급은 만료 � 5영업� 이내� 이루어질 예정입니�.

� 조치� MVF� 시장 할인율을 줄이� 장기 주주 가치를 높이� 단기 유동성을 제공하는 것을 목표� 하지�, 펀드는 할인� 감소� 대� 보장� 명시적으� 하지 않습니다. 전체 조건은 공개 매수 시작 � SEC 웹사이트에서 확인� � 있는 매수 제안� � 관� Schedule TO 문서� 자세� 나와 있습니다.

BlackRock MuniVest Fund, Inc. (NYSE : MVF) a déclenché son programme de gestion des décotes et lancera une offre publique de rachat par l’émetteur portant sur 2,5 % de ses actions ordinaires en circulation. Le déclencheur a été activé car les actions du Fonds se sont négociées avec une décote moyenne quotidienne de -7,60 % par rapport à la valeur nette d’inventaire (VNI) durant la période de mesure du 1er avril au 30 juin 2025, dépassant le seuil de 7,50 %. L’offre débutera le 15 juillet 2025 et prendra fin le 15 août 2025 à 17h00 (heure de l’Est), sauf prolongation. Les actionnaires qui présenteront leurs titres recevront 98 % de la VNI calculée le premier jour ouvrable suivant l’expiration (ou toute prolongation) de l’offre. Si les offres excèdent 2,5 % des actions en circulation, les achats seront proratisés. Le paiement est prévu dans les cinq jours ouvrables suivant l’expiration.

Cette initiative vise à réduire la décote de marché de MVF, à accroître la valeur à long terme pour les actionnaires et à fournir une liquidité à court terme, bien que le Fonds précise explicitement qu’aucune garantie ne peut être donnée quant à une réduction de la décote. Les conditions complètes seront détaillées dans l’Offre d’Achat et les documents Schedule TO associés, qui seront disponibles sur le site de la SEC dès le début de l’offre.

BlackRock MuniVest Fund, Inc. (NYSE: MVF) hat sein Discount-Management-Programm ausgelöst und wird ein Emittenten-Rückkaufangebot für 2,5 % seiner ausstehenden Stammaktien starten. Der Auslöser wurde aktiviert, weil die Aktien des Fonds im Zeitraum 1. April bis 30. Juni 2025 mit einem durchschnittlichen Tagesabschlag von -7,60% gegenüber dem Nettoinventarwert (NAV) gehandelt wurden und damit die Schwelle von 7,50 % überschritten haben. Das Rückkaufangebot beginnt am 15. Juli 2025 und endet am 15. August 2025 um 17:00 Uhr ET, sofern keine Verlängerung erfolgt. Aktionäre, die Aktien anbieten, erhalten 98 % des NAV, berechnet am ersten Geschäftstag nach Ablauf (oder Verlängerung) des Angebots. Wenn die Angebote 2,5 % der ausstehenden Aktien übersteigen, erfolgt eine Quotierung der Käufe. Die Zahlung erfolgt voraussichtlich innerhalb von fünf Geschäftstagen nach Ablauf.

Die Maßnahme soll den Marktabschlag von MVF verringern, den langfristigen Aktionärswert steigern und kurzfristige Liquidität bereitstellen, wobei der Fonds ausdrücklich darauf hinweist, dass keine Garantie für eine Reduzierung des Abschlags gegeben werden kann. Die vollständigen Bedingungen werden im Kaufangebot und den zugehörigen Schedule-TO-Unterlagen detailliert beschrieben, die auf der Website der SEC verfügbar sein werden, sobald das Angebot beginnt.

NASDAQ false 0000906709 0000906709 2025-06-30 2025-06-30
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): June 30, 2025

 

 

NEKTAR THERAPEUTICS

(Exact Name of Registrant as Specified in Charter)

 

 

 

Delaware   0-24006   94-3134940
(State or Other Jurisdiction
of Incorporation)
 

(Commission

File Number)

  (IRS Employer
Identification No.)

455 Mission Bay Boulevard South

San Francisco, California 94158

(Address of Principal Executive Offices and Zip Code)

Registrant’s telephone number, including area code: (415) 482-5300

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

symbol(s)

 

Name of each exchange
on which registered

Common Stock, $0.0001 par value   NKTR   Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 1.01

Entry into a Material Definitive Agreement.

On June 30, 2025, Nektar Therapeutics (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Jefferies LLC as the representative of the several underwriters named therein (the “Underwriters”), relating to an underwritten offering (the “Offering”) of 4,255,320 shares (the “Firm Shares”) of the Company’s common stock, $0.0001 par value per share (the “Common Stock”). The Company also granted the Underwriters a 30-day option to purchase up to an additional 638,298 shares of common stock (the “Option Shares”, together with the Firm Shares, the “Shares”) at the public offering price, less underwriting discounts and commissions. All of the Shares in the Offering were sold by the Company. Each Share was offered and sold to the public at an offering price of $23.50 per share. The offering is expected to close on July 2, 2025, subject to customary closing conditions.

The Company estimates that the net proceeds from the Offering will be approximately $93.7 million, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company, or $107.8 million, if the Underwriters exercise their option in full.

The Shares were issued pursuant to a shelf registration statement on Form S-3 (File No. 333- 286222), as filed with the U.S. Securities and Exchange Commission (“SEC”) on March 28, 2025 and declared effective on April 1, 2025. A prospectus supplement relating to the Offering has been filed with the SEC dated June 30, 2025.

The Underwriting Agreement contains customary representations, warranties, covenants, indemnification obligations of the Company and the Underwriters, including for liabilities under the Securities Act of 1933, as amended, and other obligations of the parties. The representations, warranties and covenants contained in the Underwriting Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties to such agreement, and may be subject to limitations agreed upon by the contracting parties. The foregoing is only a brief description of the terms of the Underwriting Agreement, does not purport to be a complete statement of the rights and obligations of the parties under the Underwriting Agreement and the transactions contemplated thereby, and is qualified in its entirety by reference to the Underwriting Agreement, which is filed as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference.

A copy of the legal opinion of Goodwin Procter LLP relating to the issuance and sale of the Shares in the Offering is filed as Exhibit 5.1 to this Current Report on Form 8-K and is filed with reference to, and is hereby incorporated by reference into, the Registration Statement.

 

Item 8.01

Other Events.

The full text of the press release announcing the pricing of the underwritten offering on July 1, 2025 is attached as Exhibit 99.1 hereto and is incorporated herein by reference.

Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements which can be identified by words such as: “may,” “will,” “expect,” “continue” and similar references to future periods. All statements, other than statements of historical fact, may be forward-looking statements. They are based on current expectations and projections about future events and are therefore subject to risks and uncertainties, which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Therefore, you should not rely on any of these forward-looking statements. The Company does not assume any obligation to update the forward-looking information contained in this Current Report on Form 8-K.

 


Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

 

 1.1*    Underwriting Agreement, dated June 30, 2025, between Nektar Therapeutics and Jefferies LLC as representative of the several underwriters named therein.
 5.1    Opinion of Goodwin Procter LLP.
23.1    Consent of Goodwin Procter LLP (included in Exhibit 5.1).
99.1    Press Release dated July 1, 2025.
104    Cover Page Interactive Data File (embedded within the Inline XBRL Document).

 

*

Schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    NEKTAR THERAPEUTICS
Date: July 1, 2025     By:  

/s/ Mark A. Wilson

      Mark A. Wilson
      Chief Legal Officer and Secretary

FAQ

Why is BlackRock MuniVest Fund (MVF) launching a tender offer?

MVF’s shares traded at an average discount of -7.60% to NAV, triggering its discount-management program requirement to repurchase shares.

How many MVF shares will be repurchased?

The Fund will buy back 2.5% of its outstanding common shares, subject to proration if oversubscribed.

What price will MVF pay in the tender offer?

Tendered shares will be purchased at 98% of NAV per share calculated the first business day after the offer expires.

When does the MVF tender offer start and end?

It begins 15 July 2025 and is scheduled to expire 15 August 2025 at 5:00 p.m. ET, unless extended.

Where can shareholders access the tender offer documents?

The Offer to Purchase and Schedule TO will be filed with the SEC and available free at www.sec.gov once the offer commences.
Nektar Therapeutics

NASDAQ:NKTR

NKTR Rankings

NKTR Latest News

NKTR Latest SEC Filings

NKTR Stock Data

303.35M
12.25M
1.26%
71.87%
3.59%
Biotechnology
Pharmaceutical Preparations
United States
SAN FRANCISCO